47366 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Aug 25
15:41 UTC
|
NU
NU
|
◎ Target | Darrin Peller ★★★☆☆ #1739 | Outperform | $18.00→ $17.00-5.6% |
|
Aug 25
15:41 UTC
|
MRK
Merck & Co., Inc.
|
◎ Target | Alexandria Hammond ★★★☆☆ #1561 | Outperform | $155.00→ $180.00+16.1% |
|
Aug 25
15:41 UTC
|
MA
Mastercard
|
◎ Target | Darrin Peller ★★★☆☆ #1739 | Outperform | $680.00→ $740.00+8.8% |
|
Aug 25
15:41 UTC
|
KSPI
Joint Stock Company Kaspi.kz
|
◎ Target | Darrin Peller ★★★☆☆ #1739 | Outperform | $110.00→ $115.00+4.5% |
|
Aug 25
15:41 UTC
|
JKHY
Jack Henry & Associates
|
◎ Target | Darrin Peller ★★★☆☆ #1739 | Outperform | $200.00→ $215.00+7.5% |
|
Aug 25
15:41 UTC
|
FLYW
Flywire
|
◎ Target | Darrin Peller ★★★☆☆ #1739 | Outperform | $22.00→ $23.00+4.5% |
|
Aug 25
15:41 UTC
|
FIS
Fidelity National Information Services
|
◎ Target | Darrin Peller ★★★☆☆ #1739 | Outperform | $53.00→ $54.00+1.9% |
|
Aug 25
15:41 UTC
|
EEFT
Euronet Worldwide
|
◎ Target | Darrin Peller ★★★☆☆ #1739 | Underperform | $75.00→ $70.00-6.7% |
|
Aug 25
15:41 UTC
|
CRCL
Circle Internet Group
|
◎ Target | Darrin Peller ★★★☆☆ #1739 | Underperform | $50.00→ $65.00+30.0% |
|
Aug 25
15:41 UTC
|
CPAY
Corpay
|
◎ Target | Darrin Peller ★★★☆☆ #1739 | Outperform | $475.00→ $530.00+11.6% |
|
Aug 25
15:41 UTC
|
COF
Capital One Financial
|
◎ Target | Darrin Peller ★★★☆☆ #1739 | Outperform | $255.00→ $275.00+7.8% |
|
Aug 25
15:41 UTC
|
BILL
BILL
|
◎ Target | Darrin Peller ★★★☆☆ #1739 | Outperform | $57.00→ $60.00+5.3% |
|
Aug 25
15:41 UTC
|
ASM
Avino Silver & Gold Mines
|
◎ Target | Joe Reagor not yet tracked | Neutral | $7.00→ $7.50+7.1% |
|
Aug 25
15:41 UTC
|
ACN
Accenture
|
◎ Target | Darrin Peller ★★★☆☆ #1739 | Outperform | $165.00→ $215.00+30.3% |
|
Aug 25
15:41 UTC
|
ACAD
ACADIA Pharmaceuticals
|
◎ Target | Yigal Nochomovitz ★★☆☆☆ #2797 | Buy | $39.00→ $40.00+2.6% |
|
Aug 25
14:41 UTC
|
ZTS
Zoetis
|
◎ Target | Steve Scala ★★★★☆ #570 | Buy | $104.00→ $94.00-9.6% |
|
Aug 25
14:41 UTC
|
PDD
PDD
|
◎ Target | Fawne Jiang ★☆☆☆☆ #3159 | Buy | $127.00→ $114.00-10.2% |
|
Aug 25
14:41 UTC
|
MWH
SOLV Energy
|
◎ Target | Marc Bianchi ★☆☆☆☆ #2997 | Buy | $32.00→ $35.00+9.4% |
|
Aug 25
14:41 UTC
|
GPN
Global Payments
|
◎ Target | Matthew Coad ★★★★☆ #576 | Hold | $79.00→ $95.00+20.3% |
|
Aug 25
14:41 UTC
|
GLBE
Global-e Online
|
◎ Target | Matthew Coad ★★★★☆ #576 | Buy | $41.00→ $47.00+14.6% |
|
Aug 25
14:41 UTC
|
ESTC
Elastic
|
◎ Target | Andrew Sherman ★★★★★ #22 | Hold | $55.00→ $70.00+27.3% |
|
Aug 25
14:41 UTC
|
EHTH
eHealth
|
◎ Target | Ben Hendrix ★★★★☆ #671 | Sec→ r Perform | $3.00→ $2.00-33.3% |
|
Aug 25
14:41 UTC
|
CHYM
Chime Financial
|
◎ Target | Darrin Peller ★★★☆☆ #1739 | Outperform | $32.00→ $38.00+18.8% |
|
Aug 25
14:41 UTC
|
BKR
Baker Hughes
|
◎ Target | Keith Mackey ★★★☆☆ #1664 | Outperform | $71.00→ $76.00+7.0% |
|
Aug 25
14:41 UTC
|
BIIB
Biogen
|
◎ Target | Brian Abrahams ★★☆☆☆ #2286 | Outperform | $240.00→ $260.00+8.3% |
|
Aug 25
14:41 UTC
|
ANAB
AnaptysBio
|
◎ Target | Joseph Thome ★☆☆☆☆ #2908 | Buy | $75.00→ $70.00-6.7% |
|
Aug 25
14:41 UTC
|
RLI
RLI
|
↓ Downgrade | Andrew Andersen ★★★☆☆ #1996 | Hold→ Underperform | $53.00 |
|
Aug 25
14:41 UTC
|
KLAR
Klarna Group
|
↓ Downgrade | Darrin Peller ★★★☆☆ #1739 | Outperform→ Peer Perform | |
|
Aug 25
14:41 UTC
|
ANAB
AnaptysBio
|
↓ Downgrade | firm only | Hold | $70.00 |
|
Aug 25
14:41 UTC
|
BFH
Bread Financial
|
↑ Upgrade | Darrin Peller ★★★☆☆ #1739 | Peer Perform→ Outperform | $130.00 |
|
Aug 25
13:41 UTC
|
XPEV
XPENG
|
◎ Target | Nick Lai ★☆☆☆☆ #3103 | Overweight | $27.00→ $24.00-11.1% |
|
Aug 25
13:41 UTC
|
SLG
SL Green Realty
|
◎ Target | Anthony Paolone ★★★☆☆ #1285 | Neutral | $51.00→ $61.00+19.6% |
|
Aug 25
13:41 UTC
|
RARE
Ultragenyx Pharmaceutical
|
◎ Target | Anupam Rama ★★☆☆☆ #2855 | Overweight | $75.00→ $80.00+6.7% |
|
Aug 25
13:41 UTC
|
PAYC
Paycom Software
|
◎ Target | Samik Chatterjee ★★★★☆ #915 | Neutral | $140.00→ $264.00+88.6% |
|
Aug 25
13:41 UTC
|
PANW
Palo Alto Networks
|
◎ Target | Brian Essex ★★★★☆ #678 | Overweight | $326.00→ $384.00+17.8% |
|
Aug 25
13:41 UTC
|
MRVL
Marvell Technology
|
◎ Target | Christopher Rolland ★★★☆☆ #2033 | Positive | $230.00→ $265.00+15.2% |
|
Aug 25
13:41 UTC
|
MRK
Merck & Co., Inc.
|
◎ Target | Jasper Hellweg ★★★★☆ #706 | Buy | $145.00→ $170.00+17.2% |
|
Aug 25
13:41 UTC
|
KIM
Kimco Realty
|
◎ Target | Michael Mueller ★★★☆☆ #1646 | Neutral | $25.00→ $26.00+4.0% |
|
Aug 25
13:41 UTC
|
KARD
Kardigan
|
◎ Target | Anupam Rama ★★☆☆☆ #2855 | Overweight | $51.00→ $46.00-9.8% |
|
Aug 25
13:41 UTC
|
INVH
Invitation Home
|
◎ Target | Anthony Paolone ★★★☆☆ #1285 | Overweight | $33.00→ $34.00+3.0% |
|
Aug 25
13:41 UTC
|
FIVE
Five Below
|
◎ Target | Scot Ciccarelli ★★★☆☆ #970 | Buy | $265.00→ $273.00+3.0% |
|
Aug 25
13:41 UTC
|
DLTR
Dollar Tree
|
◎ Target | Scot Ciccarelli ★★★☆☆ #970 | Buy | $136.00→ $138.00+1.5% |
|
Aug 25
13:41 UTC
|
BXP
BXP
|
◎ Target | Anthony Paolone ★★★☆☆ #1285 | Overweight | $79.00→ $87.00+10.1% |
|
Aug 25
13:41 UTC
|
ALB
Albemarle
|
◎ Target | Jeffrey Zekauskas ★★★☆☆ #1861 | Neutral | $160.00→ $140.00-12.5% |
|
Aug 25
13:41 UTC
|
ACM
AECOM
|
◎ Target | John Staszak ★★☆☆☆ #2655 | Buy | $85.00→ $75.00-11.8% |
|
Aug 25
13:41 UTC
|
VTEX
VTEX
|
↓ Downgrade | Thiago Kapulskis not yet tracked | Outperform→ Market Perform | $4.50 |
|
Aug 25
13:41 UTC
|
KLAR
Klarna Group
|
↓ Downgrade | firm only | Outperform→ Peer Perform | |
|
Aug 25
13:41 UTC
|
ANAB
AnaptysBio
|
↓ Downgrade | firm only | Hold | |
|
Aug 25
13:41 UTC
|
MRNA
Moderna
|
↑ Upgrade | Alexandria Hammond ★★★☆☆ #1561 | Underperform→ Peer Perform | |
|
Aug 25
13:41 UTC
|
FOUR
Shift4 Payments
|
↑ Upgrade | Jason Kupferberg ★★★☆☆ #1056 | Equal Weight→ Overweight | $55.00→ $59.00+7.3% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.